A reappraisal of diagnostic criteria for mucous membrane pemphigoid

Journal of Oral Pathology and Medicine

Volumn 38, Issue 1, 2009, Pages 160-

  Carrozzo, Marco ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; STEROID;

BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; EPIDERMOLYSIS BULLOSA ACQUISITA; ERYTHEMA MULTIFORME; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LETTER; LICHEN PLANUS; LUPUS ERYTHEMATOSUS; MOUTH DISEASE; MUCOUS MEMBRANE PEMPHIGOID; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN BIOPSY; STEVENS JOHNSON SYNDROME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DAPSONE; DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HUMANS; IMMUNOLOGIC TESTS; ORAL ULCER; PEMPHIGOID, BULLOUS;

EID: 58149159867     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00724.x     Document Type: Letter

References (8)

1. Arash A, Shirin L. The management of oral mucous membrane pemphigoid with dapsone and topical corticosteroid. J Oral Pathol Med 2008 37 : 341 4.
2. Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002 138 : 370 9.
3. Scully C, Carrozzo M, Gandolfo S, Puiatti P, Monteil R. Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999 88 : 56 68.
4. Calabresi V, Carrozzo M, Cozzani E, et al. Oral pemphigoid autoantibodies preferentially target BP180 ectodomain. Clin Immunol 2007 122 : 207 13.
5. Torchia D, Caproni M, Fabbri P. Linear IgA dermatosis with exclusive mucosal involvement or mucous membrane pemphigoid? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 104 : 151 2.
6. Hoffman LD, Hoffman MD. Dapsone in the treatment of persistent erythema multiforme. J Drugs Dermatol 2006 5 : 375 6.
7. Ludgate MW, Greig DE. Bullous systemic lupus erythematosus responding to dapsone. Australas J Dermatol 2008 49 : 91 3.
8. Hughes AP, Callen JP. Epidermolysis bullosa acquisita responsive to dapsone therapy. J Cutan Med Surg 2001 5 : 397 9.